Traction News and Research

RSS

Kidney Cancer Canada: Survival, support, understanding, research and hope

Survival. Support. Understanding. Research. Hope. These are five words that mean a great deal to Kidney Cancer Canada as National Kidney Month kicks off this March.

27 Feb 2010

First Edition: February 24, 2010

Today's headlines focus on the run-up to tomorrow's White House health summit as well as the latest from Capitol Hill regarding the outlook for health reform.

24 Feb 2010

Proven strategies mastered by best-in-class biopharma companies

Companies invest hundreds of millions – and occasionally billions – of dollars overall in developing new drugs and face countless hurdles in bringing these new products to market. To make good on these vast investments, successful companies must maximize product uptake across all customer groups: not only among patients and physicians, but also among government and private payers to win formulary access and improve product placement.

19 Feb 2010

NBCH's annual report: How America's health plans are doing to improve care and control costs for diabetes

Today the National Business Coalition on Health issued its annual report on how America's health plans are doing to improve care and control costs for diabetes. The analysis is based on health plan survey data from NBCH's eValue8™ program, the nation's leading Request for Information (RFI) tool used by employers, coalitions and their purchaser members to set expectations and measure health plan performance.

19 Feb 2010

Ventas reports 7.8% increase in normalized FFO for year ended December 31, 2009

Ventas, Inc. said today that normalized Funds From Operations (“FFO”) for the year ended December 31, 2009 increased 7.8 percent to $409.0 million, from $379.5 million for the comparable 2008 period.

18 Feb 2010

Patient-centered medical home concept to benefit pharmaceutical industry

HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that the pharmaceutical industry stands to gain from the patient-centered medical home concept that continues to gain traction across the country. According to the recent New England Health Plan Analysis, medical home projects seek to maintain costs and improve health through better treatment compliance, including prescription drug regimens.

18 Feb 2010

Carriage Services reports record $45.1M total revenue for fourth-quarter 2009

Carriage Services, Inc. today announced results for the fourth quarter and year ended December 31, 2009.

17 Feb 2010

Thrombogenics announces publication of positive microplasmin Phase II trial results

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.

9 Feb 2010

Searching for consensus, Dems consider potential of paring back health reform

"Passage of a comprehensive [health] bill looked impossible after the Democrats' loss of a Senate seat in Massachusetts. As an alternative, lawmakers in both parties said, some pieces of the bills already passed by the House and the Senate could be pulled out and packaged together in a measure that would command broad support."

23 Jan 2010

Natural grass/cleat combination lowers strain and less likely to cause ACL injury

Athletes put less strain on their anterior cruciate ligament (ACL) while making a cut on a natural grass surface while wearing a cleat.

21 Jan 2010

Top pharmaceutical companies choose Cegedim Dendrite's cMDM solution

Cegedim Dendrite today announced that four prominent Life Sciences companies have contracted for its Customer Master Data Management (cMDM) solution, Nucleus as a Service, within the last four months. Three of the four are among the world’s top-25 pharmaceutical companies and the fourth is a mid-sized specialty pharmaceutical company. Cegedim Dendrite is the leading provider of Customer Relationship Management (CRM), Marketing, Regulatory Compliance and Data Optimization solutions designed specifically for the Life Sciences industry.

19 Jan 2010

Mass. special election could shape fate of health reform

Los Angeles Times: "For Democrats, it's a nightmarish scenario: A Republican appears to be within striking distance of capturing the Senate seat of the late Edward M. Kennedy." Some polls now show that [Scott] Brown is gaining on Attorney General Martha Coakley, his Democratic rival.

18 Jan 2010

UK-based Andromeda Capital invests 1.25 million in TheraSim

TheraSim, Inc., the leading simulation-training company dedicated to providing online tools and solutions to reduce performance errors in healthcare and clinical research, secured a $1.25 million round of investment from UK-based Andromeda Capital.

8 Jan 2010

Methodist Hospitals' Indiana Health Facilities Financing Authority revenue bonds rated 'BB+'

Fitch Ratings assigns a 'BB+' rating to the following Indiana Health Facilities Financing Authority revenue bonds issued on behalf of Methodist Hospitals (Methodist): -- $14.6 million series 1996 Indiana Health Facilities Financing Authority revenue bonds; -- $60.6 million series 2001 Indiana Health Facilities Financing Authority revenue bonds.

24 Dec 2009

New project analyzes genetic sequence and variations of every gene expressed by 1,000 tumors

No two tumors are alike, but analyzing the genetics of cancers from different parts of the body may reveal surprising details useful for treatment and prevention.

22 Dec 2009

Suneva Medical and WTI sign credit agreement to expand growth objectives

Suneva Medical, a privately-held aesthetic medical device company, today announced that it has signed a multi-million dollar line of credit facility with Western Technology Investment (WTI).

17 Dec 2009

ThromboGenics completes enrollment in second microplasmin Phase III trial

16 Dec 2009

PURE Bioscience reports revenues for fiscal quarter ended October 31, 2009

PURE Bioscience, creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported revenues for the fiscal quarter ended October 31, 2009 of $221,900 compared with revenues of $110,600 in the same quarter of the prior fiscal year.

12 Dec 2009

Hospitals, insurers oppose health bill compromise on Medicare buy-in

Groups representing doctors and hospitals are coming out against the inclusion of a Medicare "buy-in" in the Senate health bill, The Washington Post reports. The groups joined Republicans in arguing "that a plan by liberal Democrats to allow uninsured individuals as young as 55 to buy into Medicare would be financially untenable and would jeopardize access to health-care services for millions of Americans."

10 Dec 2009

'Hidden nuggets' on work breaks and calorie counts added to health reform legislation

USA Today reports that the health care bills moving through Congress have dozens of "lesser-known provisions" that include ideas that failed to gain traction in the past but are benefiting by hitching their proposal to health care reform.

9 Dec 2009